Benzinga··Vandana SinghPfizer, Arvinas Secure FDA Approval for Groundbreaking PROTAC Breast Cancer Drug
FDA approves VEPPANU, first PROTAC therapy for advanced breast cancer with ESR1 mutations, showing 43% reduction in disease progression risk versus existing treatment.
PFEARVNGHFDA approvalbreast cancer